MRK Company Profile and Key Details
Merck & Co., Inc.
MRK Stock Price Chart
Stock Price Today
Merck & Co., Inc. (MRK) stock declined over -9.07%, trading at $90.74 on NYSE, down from the previous close of $99.79. The stock opened at $89.00, fluctuating between $87.33 and $91.23 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Company Information
| Employees | 70000 |
| Beta | 0.41 |
| Sales or Revenue | $59.87B |
| 5Y Sales Change% | 0.413% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently Asked Questions
Merck & Co., Inc. (NYSE: MRK) stock price is $90.74 in the last trading session. During the trading session, MRK stock reached the peak price of $91.23 while $87.33 was the lowest point it dropped to. The percentage change in MRK stock occurred in the recent session was -9.07% while the dollar amount for the price change in MRK stock was -$9.05.
The NYSE listed MRK is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Merck & Co., Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Lisa LeCointe-Cephas
Senior Vice President and Chief Ethics & Compliance Officer
Mr. Kenneth C. Frazier
Executive Chairman
Ms. Cristal N. Downing
Executive Vice President and Chief Communications & Public Affairs Officer
Ms. Caroline Litchfield
Executive Vice President & Chief Financial Officer
Ms. Jennifer L. Zachary
Executive Vice President & Gen. Counsel
Mr. Richard R. DeLuca Jr.
Executive Vice President & Pres of Merck Animal Health
Mr. Robert M. Davis J.D.
Chairman, Pres & Chief Executive Officer
Mr. Peter Dannenbaum
Vice President of Investor Relations
Mr. Steven C. Mizell
Executive Vice President & Chief HR Officer
Mr. Chirfi Guindo
Senior Vice President & Chief Marketing Officer for Merck Human Health
Mr. David Michael Williams
Executive Vice President and Chief Information & Digital Officer
Dr. Dean Y. Li M.D., Ph.D.
Executive Vice President & Pres of Merck Research Laboratories
Ms. Jennifer Mauer
Head of Global Communications & Corporation Brand
MRK's closing price is 3.9% higher than its 52-week low of $87.33 where as its distance from 52-week high of $134.63 is -32.6%.
Number of MRK employees currently stands at 70,000.
Official Website of MRK is: https://www.merck.com
MRK could be contacted at phone 908 740 4000 and can also be accessed through its website. MRK operates from 2000 Galloping Hill Road, Kenilworth, NJ 07033, United States.
MRK stock volume for the day was 46.21M shares. The average number of MRK shares traded daily for last 3 months was 11.65M.
The market value of MRK currently stands at $229.54B with its latest stock price at $90.74 and 2.53B of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com